Glycolipid Biosurfactants in Skincare Applications: Challenges and Recommendations for Future Exploitation.

3D in vitro skin model bioactivities bioassays biosurfactant characterisation biosurfactants glycolipids purification rhamnolipids skin cells skincare sophorolipids synthetic surfactants

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
31 May 2023
Historique:
received: 04 05 2023
revised: 24 05 2023
accepted: 29 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

The 21st century has seen a substantial increase in the industrial applications of glycolipid biosurfactant technology. The market value of the glycolipid class of molecules, sophorolipids, was estimated to be USD 409.84 million in 2021, with that of rhamnolipid molecules projected to reach USD 2.7 billion by 2026. In the skincare industry, sophorolipid and rhamnolipid biosurfactants have demonstrated the potential to offer a natural, sustainable, and skin-compatible alternative to synthetically derived surfactant compounds. However, there are still many barriers to the wide-scale market adoption of glycolipid technology. These barriers include low product yield (particularly for rhamnolipids) and potential pathogenicity of some native glycolipid-producing microorganisms. Additionally, the use of impure preparations and/or poorly characterised congeners as well as low-throughput methodologies in the safety and bioactivity assessment of sophorolipids and rhamnolipids challenges their increased utilisation in both academic research and skincare applications. This review considers the current trend towards the utilisation of sophorolipid and rhamnolipid biosurfactants as substitutes to synthetically derived surfactant molecules in skincare applications, the challenges associated with their application, and relevant solutions proposed by the biotechnology industry. In addition, we recommend experimental techniques/methodologies, which, if employed, could contribute significantly to increasing the acceptance of glycolipid biosurfactants for use in skincare applications while maintaining consistency in biosurfactant research outputs.

Identifiants

pubmed: 37298939
pii: molecules28114463
doi: 10.3390/molecules28114463
pmc: PMC10254413
pii:
doi:

Substances chimiques

Surface-Active Agents 0
Glycolipids 0
Pulmonary Surfactants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CSRD VA
ID : 1
Pays : United States

Références

Int J Mol Sci. 2016 Mar 18;17(3):401
pubmed: 26999123
Clin Med (Lond). 2021 May;21(3):170-173
pubmed: 34001566
Biotechnol Bioeng. 2011 Apr;108(4):734-41
pubmed: 21404247
Clin Dermatol. 2018 May - Jun;36(3):390-398
pubmed: 29908581
FEMS Microbiol Lett. 2009 Jan;290(2):149-55
pubmed: 19054079
Appl Microbiol Biotechnol. 2023 Jan;107(1):137-152
pubmed: 36441210
Br J Dermatol. 2008 Mar;158(3):442-55
pubmed: 18275522
Pharmaceutics. 2020 Nov 16;12(11):
pubmed: 33207832
Lett Appl Microbiol. 2015 Sep;61(3):214-23
pubmed: 25970073
Appl Microbiol Biotechnol. 2017 Apr;101(7):2865-2878
pubmed: 27988798
Arch Med Sci. 2018 Jun;14(4):910-919
pubmed: 30002710
Carbohydr Res. 2015 Oct 30;416:59-69
pubmed: 26359535
Int J Mol Sci. 2022 Sep 21;23(19):
pubmed: 36232408
Nat Rev Microbiol. 2018 Mar;16(3):143-155
pubmed: 29332945
Environ Sci Pollut Res Int. 2021 Nov;28(44):62085-62104
pubmed: 34590224
Int J Mol Sci. 2021 Nov 11;22(22):
pubmed: 34830082
Nat Prod Bioprospect. 2019 Aug;9(4):267-278
pubmed: 31214881
Crit Rev Biotechnol. 2017 Nov;37(7):911-923
pubmed: 28076995
Biotechnol Bioeng. 2016 Mar;113(3):550-9
pubmed: 26301720
Biotechnol Lett. 2012 Feb;34(2):187-95
pubmed: 22038550
Adv Exp Med Biol. 2010;672:135-45
pubmed: 20545279
J Clin Aesthet Dermatol. 2019 Jul;12(7):52-58
pubmed: 31531162
Biomed Res Int. 2013;2013:512495
pubmed: 24089681
Appl Microbiol Biotechnol. 2022 Sep;106(18):6003-6016
pubmed: 35965289
Comp Biochem Physiol C Toxicol Pharmacol. 2021 May;243:108998
pubmed: 33556537
Int J Microbiol. 2014;2014:698713
pubmed: 24669225
Cytokine. 2015 Jun;73(2):342-50
pubmed: 25585875
Appl Microbiol Biotechnol. 2016 Nov;100(22):9529-9541
pubmed: 27251547
Appl Microbiol Biotechnol. 2018 Oct;102(19):8537-8549
pubmed: 29992435
Int J Cosmet Sci. 2020 Dec;42(6):573-580
pubmed: 32572967
Biotechnol Bioeng. 2016 Dec;113(12):2644-2651
pubmed: 27317616
J Agric Food Chem. 2018 Apr 18;66(15):3922-3929
pubmed: 29595971
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2038-2047
pubmed: 27735094
Appl Microbiol Biotechnol. 2010 Jun;87(2):427-44
pubmed: 20424836
Am J Clin Dermatol. 2004;5(5):327-37
pubmed: 15554734
Methods Mol Biol. 2011;740:103-14
pubmed: 21468972
J Appl Microbiol. 2019 Jul;127(1):12-28
pubmed: 30828919
Food Res Int. 2019 Feb;116:737-744
pubmed: 30717003
Inflamm Regen. 2021 Feb 2;41(1):4
pubmed: 33526070
Front Microbiol. 2020 Jul 07;11:1477
pubmed: 32733412
Int J Mol Sci. 2021 Sep 12;22(18):
pubmed: 34576010
Front Microbiol. 2014 Sep 02;5:454
pubmed: 25228898
Drug Discov Today. 2021 Aug;26(8):1929-1935
pubmed: 33831583
Microb Cell Fact. 2019 Oct 10;18(1):164
pubmed: 31597569
Front Microbiol. 2015 Nov 26;6:1324
pubmed: 26635782
Microbiome. 2021 May 30;9(1):125
pubmed: 34053468
Curr Protoc Microbiol. 2012 May;Chapter 6:Unit 6E.1.
pubmed: 22549165
Am J Clin Dermatol. 2020 Sep;21(Suppl 1):12-17
pubmed: 32910437
Sci Rep. 2018 Feb 13;8(1):2905
pubmed: 29440668
Microb Cell Fact. 2017 Aug 5;16(1):137
pubmed: 28779757
Microorganisms. 2020 Nov 07;8(11):
pubmed: 33171837
Langmuir. 2020 Jun 2;36(21):5745-5753
pubmed: 32370512
Microb Cell Fact. 2018 Jun 8;17(1):89
pubmed: 29884194
Biomolecules. 2019 Dec 17;9(12):
pubmed: 31861084
Microbiol Mol Biol Rev. 1997 Mar;61(1):47-64
pubmed: 9106364
PLoS One. 2016 Jun 06;11(6):e0156845
pubmed: 27271048
Microbiome. 2020 Jun 5;8(1):85
pubmed: 32503672
Int J Cosmet Sci. 2009 Aug;31(4):255-61
pubmed: 19496839
Nat Rev Microbiol. 2011 Jan;9(1):27-38
pubmed: 21113182
Dermatol Ther. 2004;17 Suppl 1:16-25
pubmed: 14728695
Microb Cell Fact. 2017 Dec 14;16(1):225
pubmed: 29241456
Microb Cell Fact. 2020 Jul 20;19(1):145
pubmed: 32690027
BMC Cancer. 2009 Apr 22;9:118
pubmed: 19383172
J Colloid Interface Sci. 2014 Mar 15;418:113-9
pubmed: 24461825
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14339-44
pubmed: 14617778
Plast Reconstr Surg Glob Open. 2016 Dec 14;4(12 Suppl Anatomy and Safety in Cosmetic Medicine: Cosmetic Bootc):e1152
pubmed: 28018771
Biotechnol Lett. 2012 Sep;34(9):1597-605
pubmed: 22618240
J Oleo Sci. 2012;61(7):407-12
pubmed: 22790172
Microbiol Res. 2017 Jul;200:33-44
pubmed: 28527762
Int J Mol Sci. 2021 Feb 27;22(5):
pubmed: 33673549
Int J Mol Sci. 2021 Mar 02;22(5):
pubmed: 33801273
BMC Biol. 2019 Jun 12;17(1):47
pubmed: 31189482
Int Wound J. 2017 Feb;14(1):149-157
pubmed: 26940940
Pharmaceutics. 2022 Feb 04;14(2):
pubmed: 35214090
Colloids Surf B Biointerfaces. 2019 Sep 1;181:943-952
pubmed: 31382344
FEMS Microbiol Lett. 2016 Jan;363(2):fnv224
pubmed: 26598715
J Biosci Bioeng. 2009 Aug;108(2):142-6
pubmed: 19619862
J Wound Care. 2023 Apr 1;32(Sup4a):xxxix-xlvi
pubmed: 37029983
ChemistryOpen. 2016 Nov 23;5(6):513-516
pubmed: 28032017
Microb Cell Fact. 2017 May 30;16(1):95
pubmed: 28558761
Adv Colloid Interface Sci. 2018 Jun;256:242-255
pubmed: 29685575
Appl Microbiol Biotechnol. 2018 Jul;102(14):6163-6174
pubmed: 29752487
Biotechnol Rep (Amst). 2016 May 24;11:27-35
pubmed: 28352537
Microb Biotechnol. 2018 Sep;11(5):917-929
pubmed: 30022625
Appl Microbiol Biotechnol. 2010 May;86(5):1323-36
pubmed: 20336292
Microb Biotechnol. 2021 Jan;14(1):147-170
pubmed: 33249753
J Cosmet Dermatol. 2021 Jun;20(6):1933-1941
pubmed: 33053260
Front Bioeng Biotechnol. 2021 Nov 30;9:761266
pubmed: 34950641
mBio. 2013 Apr 30;4(3):e00003-13
pubmed: 23631911
Bioresour Technol. 2017 Feb;225:99-105
pubmed: 27888734
Molecules. 2022 Mar 21;27(6):
pubmed: 35335373
Science. 2022 May 27;376(6596):940-945
pubmed: 35617415
J Proteomics. 2014 Feb 26;98:159-74
pubmed: 24418522
Br J Dermatol. 2015 Aug;173(2):391-403
pubmed: 25939812
Nat Rev Microbiol. 2011 Apr;9(4):244-53
pubmed: 21407241
Microorganisms. 2021 Mar 05;9(3):
pubmed: 33808031
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242666
FEBS Lett. 2018 Apr;592(8):1312-1329
pubmed: 29067677
Pharmaceutics. 2021 Feb 06;13(2):
pubmed: 33562052
N Biotechnol. 2015 Dec 25;32(6):720-6
pubmed: 25738966
RSC Adv. 2020 Sep 14;10(56):34014-34032
pubmed: 35519061
J Invest Dermatol. 2021 Jan;141(1):228-231.e4
pubmed: 32522484
Biosci Biotechnol Biochem. 2021 Jun 24;85(7):1763-1771
pubmed: 33979431
Front Immunol. 2019 Dec 17;10:2950
pubmed: 31921196
Am J Clin Dermatol. 2002;3(7):445-9
pubmed: 12180892
Front Bioeng Biotechnol. 2020 Oct 22;8:594010
pubmed: 33195161
Pharmaceutics. 2022 Dec 14;14(12):
pubmed: 36559292
PLoS Pathog. 2014 Nov 13;10(10):e1004436
pubmed: 25393405
Front Oncol. 2021 Mar 16;11:622470
pubmed: 33796459
Biomolecules. 2021 Nov 19;11(11):
pubmed: 34827725
Front Immunol. 2022 Apr 06;13:840245
pubmed: 35464397
Int J Cosmet Sci. 2018 Apr;40(2):148-156
pubmed: 29355981
Anal Bioanal Chem. 2021 Jul;413(16):4311-4320
pubmed: 34003328
Trends Biotechnol. 2012 Nov;30(11):558-65
pubmed: 22901730
N Biotechnol. 2017 May 25;36:26-36
pubmed: 28065676
Molecules. 2022 Aug 29;27(17):
pubmed: 36080322
J Eur Acad Dermatol Venereol. 2010 Jan;24(1):1-6
pubmed: 19614860
Curr Protoc. 2021 Aug;1(8):e210
pubmed: 34416099
STAR Protoc. 2022 Feb 10;3(1):101172
pubmed: 35199036
Biotechnol Adv. 2022 Jan-Feb;54:107788
pubmed: 34166752
Molecules. 2022 Nov 10;27(22):
pubmed: 36431843
Methods. 2016 Jul 15;104:93-100
pubmed: 26845462
Appl Microbiol Biotechnol. 2015 Nov;99(21):9177-87
pubmed: 26272088
Front Microbiol. 2014 Dec 12;5:697
pubmed: 25566213
J Dermatol. 2020 Oct;47(10):1110-1118
pubmed: 32804417
Biomacromolecules. 2014 Nov 10;15(11):4214-27
pubmed: 25316187
Cell Biol Int. 2013 Oct;37(10):1038-45
pubmed: 23723166
Nature. 2018 Nov;563(7732):S91-S93
pubmed: 30464283
AMB Express. 2020 Nov 4;10(1):201
pubmed: 33146788
J Sci Food Agric. 2016 Oct;96(13):4310-20
pubmed: 27098847
Microb Cell Fact. 2021 Jan 4;20(1):1
pubmed: 33397389
Skin Pharmacol Physiol. 2014;27(3):141-7
pubmed: 24434680
Biomedicines. 2021 Nov 30;9(12):
pubmed: 34944618

Auteurs

Simms A Adu (SA)

The Nutrition Innovation Centre for Food and Health (NICHE), School of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine BT52 1SA, UK.

Matthew S Twigg (MS)

Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine BT52 1SA, UK.

Patrick J Naughton (PJ)

The Nutrition Innovation Centre for Food and Health (NICHE), School of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine BT52 1SA, UK.

Roger Marchant (R)

Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine BT52 1SA, UK.

Ibrahim M Banat (IM)

Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine BT52 1SA, UK.

Articles similaires

Transformation, Genetic Plants, Genetically Modified Agrobacterium Biolistics Protoplasts
Surface-Active Agents Soil Microbiology Soil Pollutants Aspergillus Aspergillus niger
Humans DNA, Viral Sodium Dodecyl Sulfate Hepatitis B virus Benzenesulfonates
Animals Diatoms Porifera Aquatic Organisms Biotechnology

Classifications MeSH